Navigation Links
Genomic Health Announces New Data Reinforcing Clinical Utility of Oncotype DX(R) in Multiple Breast Cancer Populations
Date:12/15/2009

tive breast cancer that is estrogen-receptor positive and/or progesterone-receptor positive. For more information about Oncotype DX, please visit www.oncotypedx.com.

About Genomic Health

Genomic Health, Inc. (NASDAQ: GHDX) is a life science company focused on the development and commercialization of genomic-based clinical laboratory services for cancer that allow physicians and patients to make individualized treatment decisions. In 2004, Genomic Health launched the Oncotype DX® breast cancer test, which has been shown to predict the likelihood of chemotherapy benefit as well as recurrence in early-stage breast cancer. In addition to the widely adopted Oncotype DX breast cancer test, Genomic Health is preparing to launch its Oncotype DX colon cancer test in the first quarter of 2010. The company was founded in 2000 and is located in Redwood City, California. For more information, please visit www.genomichealth.com.

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including statements relating to the company's belief that the breadth of data presented reflects the company's commitment to provide physicians and their breast cancer patients with accurate and precise clinical information that can be used to make individualized treatment decisions, the company's belief th
'/>"/>

SOURCE Genomic Health, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Genomic Health Announces Publication of Study of Oncotype DX(R) in Node-Positive Breast Cancer That Identifies Patients Who Do Not Appear to Benefit From Chemotherapy
2. New Genomic Test for Coronary Artery Disease Now Available at The Heart & Vascular Center of Arizona
3. Reminder Webcast Alert: Transgenomic, Inc. Announces Third Quarter 2009 Earnings Release Conference Call Webcast
4. Webcast Alert: Transgenomic Inc. Announces Third Quarter 2009 Earnings Release Conference Call Webcast
5. Orion Genomics Enters Discovery Collaboration and License Agreement to Advance Personalized Diagnostics
6. Transgenomic Signs Exclusive License for Cold-PCR Technology From the Dana-Farber Cancer Institute
7. Genome Quebec and Montreal Heart Institute Pharmacogenomics Centre Deploys Isilon IQ in Next Generation of Drug Development
8. CardioDx Completes Validation Study of First-Of-Its-Kind Genomic Test for Coronary Artery Disease
9. Curemark CEO Presents at Epigenomics Conference
10. Juvenile Diabetes Research Foundation, The Genomics Institute of the Novartis Research Foundation Announce Innovative Diabetes Drug Discovery and Development Partnership
11. Sirius Genomics Announces New Collaboration with Assistance Publique-Hopitaux de Paris
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2014)... Sept. 19, 2014 Today, iHealth Lab Inc. announced ... Ventures, Ltd. for its first institutional round of funding. ... iHealth,s global reach, accelerate growth and innovation, and invest ... the investment, Xiaomi Ventures will join iHealth,s board of ... infrastructure and ecommerce. "We are very pleased ...
(Date:9/19/2014)... , Sept. 19, 2014 Kiromic, LLC, a ... of Kent Hance , the former chancellor of Texas ... retired as chancellor in July 2014, after raising $1.2 billion ... that Kent Hance , the most successful chancellor in ... team not only as an investor, but also as our ...
(Date:9/19/2014)... 19, 2014  For Cloud Pharmaceuticals, Inc., a ... development, partnering is an integral part of its ... new drugs and identify early stage, preclinical, IND, ... their development. The company also partners with funds ... business model, Cloud Pharmaceuticals will be participating in ...
Breaking Medicine Technology:iHealth Raises $25 Million to Fuel Growth and Global Market Share 2Former Texas Tech Chancellor Named New Vice Chairman of the Board of Kiromic, LLC 2Cloud Pharmaceuticals Announces Partnering Sessions and Presentation Schedule 2
... Calif., Jan. 27, 2011 AVANIR Pharmaceuticals, Inc. (Nasdaq: ... release unaudited financial results for the quarter ended December ... 2011.  Keith Katkin, President and Chief Executive Officer, Randall ... and Christine Ocampo, Vice President, Finance, will host an ...
... SAN DIEGO, Jan. 27, 2011 Profil™ Institute for ... early phase clinical trials for diabetes and obesity, announced ... speaker at the Ramanbhai Foundation 5th International Symposium and ... The Ramanbhai Foundation,s International Symposium will be ...
Cached Medicine Technology:Profil Institute's CEO Presenting on Early Phase Clinical Research in India 2Profil Institute's CEO Presenting on Early Phase Clinical Research in India 3
(Date:9/21/2014)... September 21, 2014 Over the past ... drugs to inundate the market, thereby cutting into revenue ... industry. According to data from Industry Canada, the loss ... industry $1.8 and $2.5 billion in 2010 and 2012, ... patent exclusivity, which has hampered revenue growth, many pharmaceutical ...
(Date:9/21/2014)... September 21, 2014 "I want to ... and back but haven’t the money for chiropractors," said ... to have such a product for myself." , The ... to stretch the thigh muscles and align the spine ... as relieves discomfort of pinched nerves. Compact and easy ...
(Date:9/21/2014)... 21, 2014 Discount-Dress.com, a ... has recently announced its decision to implement a new ... easier for ladies across the world. Furthermore, the company ... for ladies. , The new items come in ... discounted prices, up to 56 percent off. "We are ...
(Date:9/21/2014)... September 21, 2014 More than ... been added over the past month to a ... serious cardiovascular injuries caused by the dialysis concentrate, ... updated on September 15th shows 2,089 cases filed ... District Court, District of Massachusetts. These claims were ...
(Date:9/21/2014)... 2014 Faculty and staff at Garrison Forest ... in Owings Mills, Md., kicked off the academic year by ... GFS is the first independent school to receive the bands— ... even sleep patterns— as part of a pilot program with ... walking specialty chain. The Vivofit bands are just one tool ...
Breaking Medicine News(10 mins):Health News:Brand Name Pharmaceutical Manufacturing in Canada Industry Market Research Report Now Available from IBISWorld 2Health News:Brand Name Pharmaceutical Manufacturing in Canada Industry Market Research Report Now Available from IBISWorld 3Health News:Discount-Dress.com Implements A New Shopping Cart Software And Provides New Beach Wedding Dresses 2Health News:Federal GranuFlo Litigation Adds Dozens of Cases Alleging Serious Cardiovascular Injuries, Bernstein Liebhard LLP Reports 2Health News:Federal GranuFlo Litigation Adds Dozens of Cases Alleging Serious Cardiovascular Injuries, Bernstein Liebhard LLP Reports 3Health News:Federal GranuFlo Litigation Adds Dozens of Cases Alleging Serious Cardiovascular Injuries, Bernstein Liebhard LLP Reports 4Health News:Garrison Forest School Leader in Independent School Wellness Programs 2
... , , ELMWOOD PARK, N.J. and ... its approximately 83% owned subsidiary, WebMD Health Corp. (Nasdaq: WBMD ), ... months ended June 30, 2009 at approximately 4:00 pm (ET) on Thursday, July ... on that day to discuss those results. , ...
... , ARDEE, Ireland, July 14 Warner Chilcott ... its second quarter 2009 financial results prior to the market opening on ... In addition to issuing a press release, the Company will host a ... 8:00 AM (Eastern Time) to review the results. To participate in the ...
... July 14 Earlier today a three judge panel of the ... a case considering the constitutionality of the 1995 Illinois Parental Notice of ... enjoined from enforcement until today,s ruling. The following statement can be attributed ... Illinois : , , ...
... ... Benjamin as President Obama,s pick for surgeon general. , ... Washington, DC (Vocus) June 14, 2009 --    U.S. ... surgeon general. The Alabama family physician has been an advocate for universal care, and ...
... , SAN FRANCISCO, July 14 ... Pfizer Inc. on its recently-completed divestment of three investigational compounds ... of the agreement were not disclosed. , ... Cholesterol-Aceyltransferase (ACAT) inhibitor currently in Phase 2 development for the ...
... , , SANTA MONICA, Calif., ... Dakim(R) BrainFitness(TM) System has now been adopted by 286 senior living communities ... memory loss. Dakim has added 136 new sites in the last year, ... the senior care market. , , ...
Cached Medicine News:Health News:HLTH and WebMD Announce Second Quarter Earnings Release Date and Conference Call 2Health News:U.S. African Chamber Of Commerce Congratulates U.S. on New Surgeon General, May Improve Health Care for Middle Income Families 2Health News:U.S. African Chamber Of Commerce Congratulates U.S. on New Surgeon General, May Improve Health Care for Middle Income Families 3Health News:Burrill Merchant Banking Advises Pfizer Inc. on Dermatology Portfolio Divestment 2Health News:Dakim BrainFitness Now Used in 286 Senior Living Communities, Adding 136 Sites in 12 Months for Dementia-Fighting System 2Health News:Dakim BrainFitness Now Used in 286 Senior Living Communities, Adding 136 Sites in 12 Months for Dementia-Fighting System 3
... Comfort Pick one of our pipettors up ... trigger and ejector positionsright where they should beeven ... ergonomically designed to help avoid repetitive stress injuries ... In The Palm Of Your Hand Start ...
... The total ergonomic solution and best ... Soft, feather touch action and ultra lightweight ... Stress-free tip ejection with long, lever tip ... identification , Accepts universal tips or for ...
... is ideal for all liquid handling applications ... operating buttons, and various dispensing techniques such ... make this a lab favorite. It intuitively ... pipette without any adverse effects on the ...
... Transfer an Entire Column of a 384 ... and throughput with 384 well plates, you need ... well spacing. Thats exactly what you get with ... Impact2 software (see Impact/Impact2), this innovation was specifically ...
Medicine Products: